SCIENTURE HOLDINGS, INC. (SCNX) Gets 3 Pediatric Formulary Adds for Arbli

SCIENTURE HOLDINGS, INC. announced that its Arbli (losartan) oral suspension has been added to the formularies of three prominent U.S. pediatric academic medical centers. The company also noted a sequential increase in wholesale orders.